Reinnervate
has announced that it has signed agreements with seven new European
distributors for the non-exclusive distribution of alvetex, its
breakthrough 3D cell culture technology, which won a 2011 R&D 100 award.

These
agreements mark a significant expansion of Reinnervate’s distribution network.
Under the terms of the new agreements, alvetex will be distributed and sold
under the Reinnervate brand by regional distributors of life sciences research
products—Generon (UK), Biozol GmbH (Germany), Chemie Brunschwig AG
(Switzerland), THP Medical Products (Austria), In Vitro AS (Denmark), Euroclone
(Italy), and Bio Connect (the Benelux region).

Following
the recent expansion of Reinnervate’s distribution network in Asia and
Australia the appointment of these new distributors further increases the
company’s global reach, enabling more researchers to directly access the alvetex
3D technology platform.

Reinnervate, www.reinnervate.com